USPTO serial 78376818
MELTDOSE CR
Reviewed by CopyMark Law Group
Reg. 3040173Status 710
- Filing date
- Status date
- Registration date
- Jan 10, 2006
- Examiner
- EDWARDS, ALICIA COLLINS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with MELTDOSE CR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kelly L. Williams, Esq.
KELLY L WILLIAMS ESQ EDWARDS & ANGELL LLPPO BOX 55874BOSTON, MA 02205UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations; medical preparations; and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, granules, pills, sachets, powders, and capsules; all of the above for use in the treatment of mental and physical disorders, traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalised pain | SECTION 8 - CANCELLED | — |
| 040 | Treatment of materials, namely milling, grinding, mixing, compressing, and melting of pharmaceutical or medical preparations, compounds or substances for use in the pharmaceutical and medical industries | SECTION 8 - CANCELLED | — |
| 041 | Educational training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical, and pharmaceutical fields | SECTION 8 - CANCELLED | — |
| 042 | Scientific research, namely, bacteriological research, biological research, biotechnological research, scientific research services for medical purposes and scientific research consultation; research and development for new products for others; designing and development of medical equipment; industrial design services; pharmaceutical and medical consultation regarding pharmaceutical drug development services; cosmetic research for others; design services for others in the field of medical packaging and equipment; medical research; medical and scientific research, namely, conducting clinical trials, namely, testing of medical substances and testing of medical applications; pharmaceutical drug development services, namely, development of medical applications, drug design, drug formulation, pharmaceutical formulation, and development of pharmaceutical formulations and consultation regarding pharmaceutical formulation; development of drug delivery systems for others, namely, development of solid dosage forms, pharmaceutical controlled release systems, modified release systems and pharmaceutical modified release systems and consultation related thereto; pharmaceutical drug development services, namely, development of mixing technology, development of particulate material, development of particulate material mixing technology, development of granulate technology, development of tableting technology, and consultation related thereto; materials testing for the pharmaceutical and medical industries | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LifeCycle Pharma A/S
- Other trademarks owned by LifeCycle Pharma A/S
- Other trademarks owned by LifeCycle Pharma A/S
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named MELTDOSE CR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 5, 2012 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 10, 2006 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 18, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 28, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 22, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 19, 2005 | ALIE | ASSIGNED TO LIE | — |
| Aug 19, 2005 | ALIE | ASSIGNED TO LIE | — |
| Aug 15, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 5, 2005 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 2, 2005 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 2, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 13, 2005 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 23, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2004 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2004 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2004 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Mar 29, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 29, 2004 | PAPER RECEIVED | — | |
| Mar 17, 2004 | NWAP | NEW APPLICATION ENTERED | — |